Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PGD | P52209 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1143744 | 1.00 | PDE4A (0.39) | PDE4ATSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL570718 | 0.84 | TSHR (0.33) | TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5458333 | 0.84 | TSHR (0.33) | PDE4ATSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7148889 | 0.84 | TSHR (0.33) | TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL23923262 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL1037497 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL1950299 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL6258700 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL10885691 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL23925241 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4157853-B1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC (CA) | 2024-07-31 | — | — | EP | claimed |
| CN-118304193-A | External cream capable of preventing female climacteric symptoms | 珠海众赫生物技术有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2019104213-A1 | ANTIBIOFILM FORMULATIONS AND USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-05-31 | — | — | WO | claimed |
| EP-2971254-B1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP (US) | 2019-02-20 | — | — | EP | claimed |
| CN-104080355-B | Chewing gum base containing substituted polysaccharide and the chewing gum product being produced from it | WM.雷格利 JR.公司 | 2018-05-29 | — | — | CN | claimed |
| US-20160289719-A1 | MODIFICATION OF THE XYLAN UTILIZATION SYSTEM FOR PRODUCTION OF ACIDIC XYLOOLIGOSACCHARIDES FROM LIGNOCELLULOSICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2016-10-06 | — | — | US | claimed |
| WO-2015077744-A1 | MODIFICATION OF THE XYLAN UTILIZATION SYSTEM FOR PRODUCTION OF ACIDIC XYLOOLIGOSACCHARIDES FROM LIGNOCELLULOSICS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (US) | 2015-05-28 | — | — | WO | claimed |
| US-20100152435-A1 | COMPOSITIONS AND PROCESSES FOR THE SELECTIVE CATALYTIC OXIDATION OF ALCOHOLS | STAPLEY JONATHAN A | 2010-06-17 | — | — | US | claimed |
| WO-2008113028-A1 | COMPOSITIONS AND PROCESSES FOR THE SELECTIVE CATALYTIC OXIDATION OF ALCOHOLS | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2008-09-18 | — | — | WO | claimed |
| US-20030037893-A1 | Electrophotographic paper and method for manufacturing thereof | OY KESKUSLABORATORIO - OY CENTRALLABORATORIUM AB (FI) | 2003-02-27 | — | — | US | claimed |
| EP-1272904-A1 | ELECTROPHOTOGRAPHIC PAPER AND METHOD FOR MANUFACTURING THEREOF | OY KESKUSLABORATORIO - CENTRALLABORATORIUM AB (FI) | 2003-01-08 | — | — | EP | claimed |
| WO-2001075527-A1 | ELECTROPHOTOGRAPHIC PAPER AND METHOD FOR MANUFACTURING THEREOF | OY KESKUSLABORATORIO - CENTRALLABORATORIUM AB (FI) | 2001-10-11 | — | — | WO | claimed |
| EP-0511917-B1 | Glycosylated prodrugs, process for their preparation and uses thereof | HOECHST SA LAB (FR) | 1996-10-23 | — | — | EP | claimed |
| CN-116284503-B | Xylan and preparation method and application thereof | 苏州融析生物科技有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119947692-A | Gel composition and oil-in-water composition | 株式会社资生堂 | 2025-05-06 | — | — | CN | disclosed |
| US-12127577-B2 | Compositions rich in arabinoxylan oligosaccharides | PURATOS N.V. (BE) | 2024-10-29 | — | — | US | disclosed |
| EP-0615564-A1 | METHOD AND ENZYMATIC PREPARATION FOR TREATMENT OF CELLULOSE PULPS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1994-09-21 | — | — | EP | disclosed |
| EP-0607243-A1 | METHOD FOR ENZYMATIC TREATMENT OF LIGNOCELLULOSIC MATERIALS, IN PARTICULAR CELLULOSE PULPS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1994-07-27 | — | — | EP | disclosed |
| WO-1993011296-A1 | METHOD AND ENZYMATIC PREPARATION FOR TREATMENT OF CELLULOSE PULPS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1993-06-10 | — | — | WO | disclosed |
| WO-1993007332-A1 | METHOD FOR ENZYMATIC TREATMENT OF LIGNOCELLULOSIC MATERIALS, IN PARTICULAR CELLULOSE PULPS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152435-A1 | COMPOSITIONS AND PROCESSES FOR THE SELECTIVE CATALYTIC OXIDATION OF ALCOHOLS | ADH1C, UGGT1, ADH1A | PDE4A 2231/4885TSHR 3052/4885SLC1A3 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.